Somak Chattopadhyay
Founder and Managing Partner @ Armory Square Ventures
Syracuse, United States
Somak Chattopadhyay is a Series A investor at Armory Square Ventures in Syracuse focused on Software and Health Care. Somak Chattopadhyay is the Founder and Managing Partner at Armory Square Ventures. Additionally, Somak Chattopadhyay has had 4 past jobs including Investment Committee Member at Female Founders Fund. He attended the Massachusetts Institute of Technology and Columbia Business School.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Somak Chattopadhyay invests in
Stages Somak Chattopadhyay invests in
Countries Somak Chattopadhyay invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $3M–$5.5M
- Series A
- $5.5M–$16M
Investment Focus
Industry
- Software 4 (50%)
- Health Care 2 (25%)
- Information Technology 2 (25%)
- Artificial Intelligence 2 (25%)
- SaaS 1 (13%)
Stage
- Series A 3 (38%)
- Seed 2 (25%)
- Series B 1 (13%)
- Venture - Series Unknown 1 (13%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Thoughtfully assists companies in creating and implementing AI speech agents that mimic humans. | $5.5M / Seed / Apr 22, 2026 | ||
| At BQP, we’re developing a quantum-accelerated digital twin platform for mission-critical applications. The platform, BQPhy, is a back-end engine that integrates seamlessly into existing engineering workflows and operates on today’s infrastructure without requiring quantum hardware. BQPhy helps teams solve large-scale, complex challenges inengineering optimization, data-driven modeling (ML), and physics-based (CFD) simulations. We are bridging the gap between current high-performance computers and future quantum systems with probabilistic algorithms from quantum information science, unlocking simulation capabilities that were previously impractical or impossible. BQPhy reduces time, accuracy, and throughput inefficiencies, thereby accelerating development cycles, unlocking previously unexplored design spaces, lowering costs, and enhancing product outcomes. | $3M / Seed / Dec 17, 2024 | ||
| Machinery Partner helps buyers and sellers of heavy equipment to grow faster and easier with the technology and industry expertise to match their needs. | $8M / Series A / Dec 05, 2023 | ||
| RealEats is a food tech company that offers a premium meal prep delivery service. Its first product innovation is a line of healthy hyper-convenient meals that reduce food waste. RealEats meals are delivered directly to consumers. Its products are chef-designed, nutritionally rich, and made from whole, unprocessed, responsibly sourced, junk-freeingredients, many of which are from local farms in the Finger Lakes agricultural region of New York State where the company's kitchen is located. | $16.3M / Series A / Oct 26, 2021 | ||
| UCM Digital Health is a provider of virtual care and emergency telemedicine tools for insurers, employers, patients, and providers. The company's digital front door platform enables the creation of lower-cost, high-quality offerings through a single point of digital engagement with intelligent network routing, backed by 24/7/365emergency medicine provider treatment, triage, and navigation when needed.UCM Digital Health was founded in 2014 and is based in Troy, New York. | $5.5M / Series A / Apr 28, 2021 | ||
| StorySlab is a tablet selling system that makes it easy to share a better sales story, extend marketing’s reach, and satisfy IT requirements.The platform features enable frictionless selling. Each project is a custom-configured app, web CMS and secure cloud storage for a unique user and prospect experience with full offline functionality.StorySlab was founded in 2012 and is based in Syracuse, New York. | $2.7M / Venture - Series Unknown / Apr 03, 2020 | ||
| Truveris brings transparency to the prescription drug ecosystem through data-driven innovations. Truveris’ platform offers customers – from the individual patient to employers, retailers, pharmacy benefits stakeholders, and manufacturers – the data and insights they need to effectively and efficiently manage rising costs and market accesschallenges.Based in Manhattan, Truveris is backed by Canaan Partners, New Leaf Venture Partners, Tribeca Venture Partners, New Atlantic Ventures and First Round Capital. | $10M / Series B / Feb 23, 2012 | ||
| See all 8 investments → | |||
Co-Investors
About Armory Square Ventures
Armory Square Ventures is an early-stage VC fund focused on B2B software, mobile, and technology-enabled services in under-ventured regions.
Armory Square Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Anthony Santaro
Associate
|
|||
Jackson Feder
Analyst
|
|||
John Cococcia
Venture Partner
|
|||
Neenah Jain
Partner & CFO
|
|||
Pia Sawhney
Director of Strategy
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Somak Chattopadhyay invest in?
Somak Chattopadhyay invests primarily in Software, Health Care and Information Technology startups, most often at Series A and Seed stage. Most of the 8 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Somak Chattopadhyay invest in?
Somak Chattopadhyay typically joins rounds of $3M–$5.5M at Seed and $5.5M–$16M at Series A. These are whole funding-round sizes, not Somak Chattopadhyay's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Somak Chattopadhyay took part in.
How do I contact Somak Chattopadhyay?
Public channels for Somak Chattopadhyay include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Somak Chattopadhyay last invest?
The most recent investment recorded for Somak Chattopadhyay closed in Apr 2026. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
